Abstract:Osteoporosis is a disease characterized by low bone mass and alterations of bone microarchitecture, with an increased risk of fractures. It is a multifactorial disorder that is more frequent in postmenopausal women but can be associated to other diseases (inflammatory and metabolic diseases). At present, several options are available to treat osteoporosis trying to block bone reabsorption and reduce the risk of fracture. Anyway, these drugs have safety and tolerance problems in long-term treatment. Recently, gut microbiota has been highlighted to have strong influence on bone metabolism, becoming a potential new target to modify bone mineral density. Such evidences are mainly based on mouse models, showing an involvement in modulating the interaction between the immune system and bone cells. Germ-free mice represent a basic model to understand the interaction between microbiota, immune system, and bone cells, even though data are controversial. Anyway, such models have unequivocally demonstrated a connection between such systems, even if the mechanism is unclear. Gut microbiota is a complex system that influences calcium and vitamin D absorption and modulates gut permeability, hormonal secretion, and immune response. A key role is played by the T helper 17 lymphocytes, TNF, interleukin 17, and RANK ligand system. Other important pathways include NOD1, NOD2, and Toll-like receptor 5. Prebiotics and probiotics are a wide range of substances and germs that can influence and modify microbiota. Several studies demonstrated actions by different prebiotics and probiotics in different animals, differing according to sex, age, and hormonal status. Data on the effects on humans are poor and controversial. Gut microbiota manipulation appears a possible strategy to prevent and treat osteopenia and/or osteoporosis as well as other possible bone alterations, even though further clinical studies are necessary to identify correct procedures in humans.

From Osteoimmunology to Osteomicrobiology: How the Microbiota and the Immune System Regulate Bone

Bone Remodeling and the Microbiome

The Interplay between Immune System and Microbiota in Osteoporosis

Emerging Insights into the Endocrine Regulation of Bone Homeostasis by Gut Microbiome

"Osteomicrobiology": The Nexus Between Bone and Bugs

Role of Dietary Supplements and Probiotics in Modulating Microbiota and Bone Health: The Gut-Bone Axis

Gut Microbiota Modulates Osteoclast Glutathione Synthesis and Mitochondrial Biogenesis in Mice Subjected to Ovariectomy

Gut Microbiome and Osteoporosis

The Role of Probiotics and Prebiotics in Osteolastogenesis and Immune Relevance

The role of short-chain fatty acids in the regulation of osteoporosis: new perspectives from gut microbiota to bone health: A review

Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis

Gut microbiota: an overlooked factor that plays a significant role in osteoporosis

Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis

Unequivocal Dyad of Gut Microbiome and Osteo Integrity- Dynamic Cross-Talk and Implications in Osteoporosis Management

Physical Exercise and Gut Microbiota in the Aging Process: From Osteoporosis to Preventive Bone Health Strategy

Gut Microbiota, Immune System, and Bone

The potential mechanism of the microbiota-gut-bone axis in osteoporosis: a review

Bone Homeostasis and Gut Microbial-Dependent Signaling Pathways

The microbiota-gut-bone axis and bone health

Microbiota metabolites in bone: Shaping health and Confronting disease

Microbiome’s Role in Musculoskeletal Health Through the Gut-Bone Axis Insights